|

The Rise in Robotic Atypical Segmentectomies

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2020-09-15
Est. completion2027-04-30
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04644952

Summary

This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients who underwent a lung resection from 2004 to 2019

Conditions3

CancerLung CancerLung Carcinoma

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
David C. Rice713-563-9153

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.